|
|
Science Sparks @ ACTREC
|
17th February 2025 |
Vol. No. 14 ; Issue No.670 |
|
Publications
|
1. Saha A, Goswami D, Hole A, Bendale K, Chaudhari P, CM Krishna (2025). Serum Raman spectroscopy explorations in Canine cancers: A pilot study. Journal of Raman Spectroscopy.
2. Bhat M, Saha P, Narasimhan M, Shelar A, Hole A, Murali Krishna C, Govekar R (2025). Analysis of lipids by Raman spectroscopy and mass spectrometry provides a detection tool and mechanistic insight into imatinib resistance in CML-BC. Biochimica et Biophysica Acta (BBA) - General Subjects.
3. Jadhav PA, Hole A, Saha P, Pansare K, Ghanwat A, Gera P, Bendale K, Krishna CM, Chaudhari P (2025). Exploratory Raman Spectroscopic Studies of Canine Oral Tumour Types. Journal of Biophotonics.
4. Ghosh A, Chaubal R, Das C, Parab P, Das S, Maitra A, Majumder PP, Gupta S, Biswas NK (2025). Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours. Communications Biology. 8(1):207.
5. Shivshankar S, Patil PS, Deodhar K, Budukh AM (2025). Epidemiology of colorectal cancer: A review with special emphasis on India. Indian Journal of Gastroenterology.
6. Keshari R, Bagale R, Rath S, De A, Banerjee R, Sen S, Srivastava R (2025). Transcutaneous delivery of disease-specific PI3K/Akt/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies. International Journal of Pharmaceutics.
|
|
|
Interesting Reads
|
Kumarasamy V, Wang J, Roti M, Wan Y, Dommer AP, Rosenheck H, Putta S, Trub A, Bisi J, Strum J, Roberts P, Rubin SM, Frangou C, McLean K, Witkiewicz AK, Knudsen ES (2025). Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. Nature Communications. 16(1):1476.
|
|
Video of the Week
|
|
Imaging Molecules at Work: Illuminating Disease Biology In Vivo |
|
|
|
|
|
Upcoming Events
|
|
7th Indian Cancer Genetics Conference & Workshop (ICGCW 2025)
|
22-23 February 2025
|
ICGC2025 Conference (Choksi Auditorium, TMH): 22-23 Feb 2025
Pre-conference NGS Hands on Workshop at ACTREC Navi Mumbai: 20-21st February 2025
Pre-conference Genetic Counselling (GC) Workshop at TMH, Mumbai: 20-21st February 2025.
|
|
|
|
|
|
|
|
|
|
Do You Know?
In 2009, FDA approved Cervarix, a second vaccine that protects against infection by the two HPV types that cause approximately 70% of all cases of cervical cancer worldwide.
|
|
|
Cancer News
|
|
Towards a Cancer-Free India : Commitment to Prevention, Treatment & Innovation.
|
Press Information Bureau, 13/02/2025
|
The Government of India has introduced robust policies, strategic interventions, and financial assistance schemes to enhance prevention, early detection, treatment, and patient care nationwide. This article outlines cancer prevalence, government efforts, financial aid, research
...
|
|
Landmark atlas reveals how aging breast tissue shapes breast cancer risk.
|
MedicalXpress, 13/02/2025
|
Researchers for the first time, established a direct link between aging-related gene expression changes and chromatin accessibility in the mammary gland, which refers to how tightly or loosely DNA is packed within the nucleus. This affects which genes can be turned on or off...
|
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|